Expression of autocrine motility factor mRNA is a poor prognostic factor in high‐grade astrocytoma
- 24 August 2006
- journal article
- Published by Wiley in Pathology International
- Vol. 56 (9) , 510-515
- https://doi.org/10.1111/j.1440-1827.2006.01999.x
Abstract
It has been reported that tumor infiltration is correlated with the expression of autocrine motility factor (AMF) and its receptor 78 kDa glycoprotein (gp78). The purpose of the present study was to detect AMF and gp78 mRNA expression levels and their localization in high‐grade astrocytomas (glioblastoma and anaplastic astrocytoma) and to determine whether AMF and gp78 are important prognostic factors. A total of 32 formalin‐fixed and paraffin‐embedded glioblastomas and 23 formalin‐fixed and paraffin‐embedded anaplastic astrocytomas was used. The expressions of AMF and gp78 mRNA were detected using the highly sensitive in situ hybridization method. The expression of AMF mRNA was detected in 27 of 32 glioblastomas (84.4%) and 11 of 23 anaplastic astrocytomas (47.8%). The positivity of AMF mRNA was significantly higher in glioblastomas than in anaplastic astrocytomas (P = 0.0094), but gp78 mRNA was detected in most cases and no statistical significance was observed. The overall survival of patients with AMF expression was significantly shorter than patients without AMF expression (P = 0.0175). In anaplastic astrocytomas, the overall survival of patients with AMF expression was also significantly shorter than in patients without AMF expression (P = 0.0058). This study demonstrated that AMF is a poor prognostic factor in high‐grade astrocytomas.Keywords
This publication has 28 references indexed in Scilit:
- Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast CancerJournal of Histochemistry & Cytochemistry, 2006
- Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxiaThe FASEB Journal, 2005
- Expression of Autocrine Motility Factor Correlates with the Angiogenic Phenotype of and Poor Prognosis for Human Gastric CancerClinical Cancer Research, 2005
- Negative and positive regulation of HIF-1: A complex networkBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2005
- Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancyEndocrine-Related Cancer, 2004
- Autocrine Motility Factor Signaling Enhances Pancreatic Cancer MetastasisClinical Cancer Research, 2004
- Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosisJournal of Cell Science, 2003
- Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf‐1 and Caspase‐9 apoptosome expressionInternational Journal of Cancer, 2003
- Regulation of Cell Proliferation by Autocrine Motility Factor/Phosphoglucose Isomerase SignalingJournal of Biological Chemistry, 2003
- Correlation Between Loss of E-Cadherin Expression and Overexpression of Autocrine Motility Factor Receptor in Association With Progression of Human Gastric CancersAmerican Journal of Clinical Pathology, 2000